Drugs in MeSH Category Neuroprotective Agents
✉ Email this page to a colleague
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mylan Technologies | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 205622-002 | Jun 20, 2018 | AB | RX | No | No | ⤷ Free Trial | ⤷ Free Trial | ⤷ Free Trial | |||
Amneal Pharms | RIVASTIGMINE | rivastigmine | FILM, EXTENDED RELEASE;TRANSDERMAL | 207308-003 | Jan 8, 2019 | AB | RX | No | No | ⤷ Free Trial | ⤷ Free Trial | ⤷ Free Trial | |||
Somerset | EMSAM | selegiline | FILM, EXTENDED RELEASE;TRANSDERMAL | 021336-001 | Feb 27, 2006 | RX | Yes | Yes | ⤷ Free Trial | ⤷ Free Trial | ⤷ Free Trial | ||||
Novast Labs | METHYLPREDNISOLONE | methylprednisolone | TABLET;ORAL | 210985-001 | Jan 9, 2019 | DISCN | No | No | ⤷ Free Trial | ⤷ Free Trial | ⤷ Free Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |